IGMS: IGM Biosciences Inc. Sotuvga nisbatan narx
IGM Biosciences, Inc. (IGMS) kompaniyasidagi yuqori daromadlilik laboratoriya diversifikatsiyasi va optimallashtirilgan sovuq zanjir logistikasi bilan ta'minlanmoqda. Bozor kapitalizatsiyasining daromadga nisbati biznesning baholanishini aniq ko'rsatadi, bunda ushbu ko'rsatkich 0.30 darajasida turibdi. Yetakchi biologlar jamoasi noyob muhandislik platformasiga asoslangan kelajakdagi farmatsevtika vositalarini yaratmoqda. Makroiqtisodiy tebranishlardan mustaqillik ushbu innovatsion ishlanmalarni ishonchli himoya aktiviga aylantiradi.
IGM Biosciences, Inc. (IGMS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati igmbio.com|IGMS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati IGM Bio|IGMS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi IGM Biosciences|Shoshilinch likvidlik igmbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
IGMS - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi IGM Biosciences, Inc.|IGMS - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati igmbio.com|IGMS - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati IGM Bio|IGMS - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda IGM Biosciences|IGMS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi igmbio.com|IGMS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi IGM Biosciences, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:IGM Biosciences Inc. IGMS
IGM Biosciences, Inc. (IGMS) uchun bozor qiymatini tushumlar prizmasi orqali baholash kapitalizatsiya va biologik preparatlarning tijoratlashtirish samaradorligi o'rtasidagi bog'liqlikni aniqlash imkonini beradi, bunda antitelolarning faolligini saqlash uchun murakkab sovuq zanjir logistikasi talab etiladi. Narx/savdo ko'rsatkichini tahlil qilish orqali investor bozor narxi va savdo hajmi o'rtasidagi bog'liqlikni ko'rishi mumkin, bu esa fundamental o'sish omillarini tezda aniqlashga va baholash cho'qqilari paytida kelajakdagi kutuvlar uchun haddan tashqari ko'p to'lov qilishdan qochishga yordam beradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|IMVT: P/S multiplikatori|Narx/daromad multiplikatori kiniksa.com KNSA|Narxning daromadga nisbati Grifols|Kapitalizatsiyaning daromadga nisbati Adaptive Biotech (ADPT)|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|veratx.com - Narxning daromadga nisbati|Dianthus Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Sotuvga nisbatan narx Tourmaline (TRML)|Narxning daromadga nisbati Precigen, Inc.|pharming.com (PHAR) - Narx/daromad koeffitsiyenti|P/S multiplikatori NKTR|Kapitalizatsiyaning daromadga nisbati Upstream Bio, Inc. UPB|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx/daromad koeffitsiyenti Immunome Bio (IMNM)|Gossamer Bio, Inc. - P/S multiplikatori|Sotuvga nisbatan narx kalvista.com|Septerna (SEPN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati PVLA|SVRA (Savara Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Rigel Corp (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics Inc. (RAPT)|JBIO: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACRS (Aclaris Therapeutics, Inc)|KYTX: P/S multiplikatori|TLSA - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Cabaletta Bio|Kapitalizatsiya va daromad nisbati VTYX (Ventyx Biosciences Inc.)|P/S multiplikatori THTX|Kapitalizatsiyaning daromadga nisbati Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti agenusbio.com (AGEN)|Climb Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Zura Bio Ltd ZURA|ATYR: P/S multiplikatori|Narx/daromad multiplikatori Adagene Inc. ADAG|Narxning daromadga nisbati ImageneBio|Kapitalizatsiyaning daromadga nisbati Shattuck Therapeutics (STTK)|Narxning daromadga nisbati Equillium, Inc. (EQ)|Narx/daromad koeffitsiyenti connectbiopharm.com|Narxning daromadga nisbati Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Narxning sotuvga nisbati|InflaRx GmbH - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati XFOR (x4pharma.com)|ACET: P/S multiplikatori|Celularity (CELU) - P/S multiplikatori|Narxning daromadga nisbati INmune Bio Corp|BRNS: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kezar Life Sciences (KZR)|Kapitalizatsiyaning daromadga nisbati sabbiotherapeutics.com SABS|P/S multiplikatori AKTX (Akari Therapeutics Plc)|P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati GOVX (GeoVax Corp)|EDSA: P/S multiplikatori|IBIO - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Carisma Therapeutics Inc|Kapitalizatsiyaning daromadga nisbati XTL Biopharmaceuticals Ltd (XTLB)|Narxning daromadga nisbati Bolt Biotherapeutics (BOLT)|Kapitalizatsiyaning daromadga nisbati hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori AIM ImmunoTech, Inc. AIM|ADTX - Narxning daromadga nisbati|GRI (GRI Bio Inc) - Kapitalizatsiya va daromad nisbati|XRTX: P/S multiplikatori|Sotuvga nisbatan narx Vyome Therapeutics (HIND)|REVB (Revelation Biosciences) - P/S multiplikatori|indaptusrx.com (INDP) - Narx/daromad koeffitsiyenti|P/S multiplikatori SCNI|calcimedica.com (CALI) - Narx/daromad multiplikatori|Narxning daromadga nisbati Affimed N.V. AFMD|ALLK - Kapitalizatsiyaning daromadga nisbati|HOOK: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iteostherapeutics.com)|OCEA: P/S multiplikatori|TCBP (TC BioPharm (Holdings) Plc) - Narxning daromadga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
